NON CONTROLLING INTEREST |
12 Months Ended |
---|---|
Dec. 31, 2017 | |
Notes to Financial Statements | |
Note 17 - NON CONTROLLING INTEREST |
On July 28, 2016, the Company formed BioCorRx Pharmaceuticals, Inc., a Nevada Corporation, for the purpose of developing certain business lines. In connection with the formation, the, the newly formed sub issued 21.9% ownership to officers of the Company with the Company retaining 78.1%. From inception through December 31, 2017, there were no significant transactions, assets or liabilities in BioCorRx Pharmaceuticals, Inc., or operations since its formation. |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|